The Quarterly
ARTW 2016 10-K

Arts Way Manufacturing Co Inc (ARTW) SEC Quarterly Report (10-Q) for Q1 2017

ARTW Q2 2017 10-Q
ARTW 2016 10-K ARTW Q2 2017 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[x]

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended February 28, 2017

or

[  ]

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ______ to ______

Commission File No. 0-5131

ART'S-WAY MANUFACTURING CO., INC.

(Exact name of registrant as specified in its charter)

DELAWARE

42-0920725

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

5556 Highway 9

Armstrong, Iowa 50514

(Address of principal executive offices)

(712) 864-3131

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.:

Large accelerated filer [ ] 

Accelerated filer [ ]

Non-accelerated filer [ ]    Smaller reporting company [x]
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [ ] No [x]

Number of common shares outstanding as of March 17, 2017: 4,156,752

Art's-Way Manufacturing Co., Inc.

Index

Page No.

PART I – FINANCIAL INFORMATION

  1

Item 1.

Financial Statements

 1

Condensed Consolidated Balance Sheets February 28, 2017 and November 30, 2016   1

Condensed Consolidated Statements of Operations Three-month periods ended February 28, 2017 and February 29, 2016   2

Condensed Consolidated Statements of Comprehensive Income Three-month periods ended February 28, 2017 and February 29, 2016   3

Condensed Consolidated Statements of Cash Flows Three-month periods ended February 28, 2017 and February 29, 2016   4

Notes to Condensed Consolidated Financial Statements

  5

Item 2. 

Management's Discussion and Analysis of Financial Condition and Results of Operations

  17

Item 3.

Quantitative and Qualitative Disclosures About Market Risk   20

Item 4.

Controls and Procedures

 20

PART II – OTHER INFORMATION

20

Item 1.

Legal Proceedings

 20

Item 1A.

Risk Factors   20

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 21

Item 3.

Defaults Upon Senior Securities

 21

Item 4.

Mine Safety Disclosures

 21

Item 5.

Other Information

 21

Item 6.

Exhibits

 21

SIGNATURES

  22

Exhibit Index

  23

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

ART'S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Balance Sheets

(Unaudited)

February 28, 2017

November 30, 2016

Assets

Current assets:

Cash

$ 750,779 $ 1,063,716

Accounts receivable-customers, net of allowance for doubtful accounts of $17,145 and $22,746 in 2017 and 2016, respectively

1,458,539 1,420,051

Inventories, net

13,233,377 13,529,352

Deferred income taxes

- 1,066,740

Cost and profit in excess of billings

119,662 108,349

Income taxes receivable

271,461 265,924

Assets of discontinued operations

7,500 9,700

Other current assets

414,070 158,087

Total current assets

16,255,388 17,621,919

Property, plant, and equipment, net

7,398,748 7,387,187

Assets held for sale, net

70,000 70,000

Goodwill

375,000 375,000

Other assets of discontinued operations

1,716,565 1,745,528

Deferred income taxes

436,255 -

Other assets

40,620 42,956

Total assets

$ 26,292,576 $ 27,242,590

Liabilities and Stockholders' Equity

Current liabilities:

Line of credit

$ 3,034,114 $ 3,284,114

Current portion of long-term debt

2,673,128 1,807,937

Accounts payable

550,115 469,481

Customer deposits

792,897 289,195

Billings in Excess of Cost and Profit

75,032 4,297

Accrued expenses

852,407 1,019,056

Liabilites of discontinued operations

717,235 182,426

Total current liabilities

8,694,928 7,056,506

Long-term liabilities

Deferred taxes

- 737,519

Long-term liabilities of discontinued operations

- 585,168

Long-term debt, excluding current portion

339,808 1,387,118

Total liabilities

9,034,736 9,766,311

Commitments and Contingencies (Notes 7 and 8)

Stockholders' equity:

Undesignated preferred stock - $0.01 par value. Authorized 500,000 shares in 2017 and 2016; issued 0 shares in 2017 and 2016.

- -

Common stock – $0.01 par value. Authorized 9,500,000 shares in 2017 and 2016; issued 4,156,752 in 2017 and 4,109,052 in 2016

41,568 41,091

Additional paid-in capital

2,772,589 2,746,509

Retained earnings

14,740,882 14,990,911

Accumulated other comprehensive income

(291,210 ) (302,232 )

Treasury stock, at cost (1,838 in 2017 and 0 in 2016 shares)

(5,989 ) -

Total stockholders' equity

17,257,840 17,476,279

Total liabilities and stockholders' equity

$ 26,292,576 $ 27,242,590

See accompanying notes to condensed consolidated financial statements.

1

ART'S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Statements of Operations

(Unaudited)

Three Months Ended

February 28, 2017

February 29, 2016

Sales

$ 4,421,168 $ 5,712,681

Cost of goods sold

3,307,345 4,084,798

Gross profit

1,113,823 1,627,883

Expenses:

Engineering

132,640 99,416

Selling

485,380 464,913

General and administrative

848,236 842,586

Total expenses

1,466,256 1,406,915

Income (Loss) from operations

(352,433 ) 220,968

Other income (expense):

Interest expense

(63,794 ) (67,839 )

Other

51,674 42,187

Total other income (expense)

(12,120 ) (25,652 )

Income (Loss) from continuing operations before income taxes

(364,553 ) 195,316

Income tax expense (benefit)

(110,911 ) 61,767

Income (Loss) from continuing operations

(253,642 ) 133,549

Discontinued Operations

Income (loss) from operations of discontinued segment

4,877 (75,124 )

Income tax expense (benefit)

1,264 (22,537 )

Income (Loss) on discontinued operations

3,613 (52,587 )

Net Income (Loss)

(250,029 ) 80,962

Earnings (Loss) per share - Basic:

Continuing Operations

$ (0.06 ) $ 0.03

Discontinued Operations

$ 0.00 $ (0.01 )

Net Income (Loss) per share

$ (0.06 ) $ 0.02

Earnings (Loss) per share - Diluted:

Continuing Operations

$ (0.06 ) $ 0.03

Discontinued Operations

$ 0.00 $ (0.01 )

Net Income (Loss) per share

$ (0.06 ) $ 0.02

Weighted average outstanding shares used to compute basic net income per share

4,126,012 4,074,338

Weighted average outstanding shares used to compute diluted net income per share

4,126,012 4,074,338

See accompanying notes to condensed consolidated financial statements.

2

ART'S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

Three Months Ended

February 28, 2017

February 29, 2016

Net Income (Loss)

$ (250,029 ) $ 80,962

Other Comprehensive Income (Loss)

Foreign currency translation adjustsments

11,022 -

Total Other Comprehensive Income (Loss)

11,022 -

Comprehensive (Loss)

$ (239,007 ) $ 80,962

See accompanying notes to condensed consolidated financial statements.

3

ART'S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Three Months Ended

February 28, 2017

February 29, 2016

Cash flows from operations:

Net income (loss) from continuing operations

$ (253,642 ) $ 133,549

Net income (loss) from discontinued operations

3,613 (52,587 )

Adjustments to reconcile net (loss) to net cash provided by operating activities:

Stock based compensation

26,557 11,252

(Gain)/Loss on disposal of property, plant, and equipment

2,463 (40,067 )

Depreciation and amortization expense

170,789 173,303

Bad debt expense

5,601 17,046

Deferred income taxes

(107,034 ) 1,263

Changes in assets and liabilities:

(Increase) decrease in:

Accounts receivable

(44,089 ) (585,088 )

Inventories

295,975 862,920

Income taxes receivable

(5,537 ) 35,778

Other assets

(255,629 ) (198,801 )

Increase (decrease) in:

Accounts payable

80,634 53,272

Contracts in progress, net

59,422 87,430

Customer deposits

503,702 239,094

Accrued expenses

(166,649 ) (212,033 )

Net cash provided by operating activities - continuing operations

312,563 578,918

Net cash provided by (used in) operating activities - discontinued operations

(22,039 ) 40,620

Net cash provided by operating activities

290,524 619,538

Cash flows from investing activities:

Purchases of property, plant, and equipment

(195,020 ) (26,257 )

Net proceeds from sale of assets

12,190 1,170,642

Net cash provided by (used in) investing activities - continuing operations

(182,830 ) 1,144,385

Net cash provided by (used in) investing activities - discontinued operations

38,736 (8,437 )

Net cash provided by (used in) investing activities

(144,094 ) 1,135,948

Cash flows from financing activities:

Net change in line of credit

(250,000 ) (169,481 )

Repayment of term debt

(182,119 ) (1,372,767 )

Repurchases of common stock

(5,989 ) -

Net cash (used in) financing activities - continuing operations

(438,108 ) (1,542,248 )

Net cash (used in) financing activities - discontinued operations

(32,281 ) (31,313 )

Net cash (used in) financing activities

(470,389 ) (1,573,561 )
Effect of exchange rate changes on cash 11,022 -

Net increase (decrease) in cash

(312,937 ) 181,925

Cash at beginning of period

1,063,716 447,334

Cash at end of period

$ 750,779 $ 629,259

Supplemental disclosures of cash flow information:

Cash paid during the period for:

Interest

$ 71,338 $ 79,357

Income taxes

$ 3,125 $ -

See accompanying notes to condensed consolidated financial statements.

4

Notes to Unaudited Condensed Consolidated Financial Statements

1)

Description of the Company

Unless otherwise specified, as used in this Quarterly Report on Form 10-Q, the terms "we," "us," "our," "Art's-Way," and the "Company," refer to Art's-Way Manufacturing Co., Inc., a Delaware corporation headquartered in Armstrong, Iowa, and its wholly-owned subsidiaries.

We began operations as a farm equipment manufacturer in 1956. Since that time, we have become a major worldwide manufacturer of agricultural equipment. Our principal manufacturing plant is located in Armstrong, Iowa.

We have organized our business into three operating segments. Management separately evaluates the financial results of each segment because each is a strategic business unit offering different products and requiring different technology and marketing strategies. Our agricultural products segment ("Manufacturing") manufactures farm equipment under the Art's-Way Manufacturing label and private labels. Our modular buildings segment ("Scientific") manufactures modular buildings for various uses, commonly animal containment and research laboratories and our tools segment ("Metals") manufactures steel cutting tools and inserts. During the third quarter of fiscal 2016, we discontinued our pressurized vessels segment ("Vessels") that manufactured pressurized vessels. For more information on discontinued operations, see Note 3 "Discontinued Operations." For detailed financial information relating to segment reporting, see Note 13 "Segment Information."

5

2)

Summary of Significant Account Policies

Statement Presentation

The foregoing condensed consolidated financial statements of the Company are unaudited and reflect all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the interim periods. The financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 2016. The results of operations for the three months ended February 28, 2017 are not necessarily indicative of the results for the fiscal year ending November 30, 2017.

The financial books of our Canadian operation are kept in the functional currency of Canadian dollars and the financial statements are converted to U.S. Dollars for consolidation. When consolidating the financial results of the Company into U.S. Dollars for reporting purposes, the Company uses the All-Current translation method. The All-Current method requires the balance sheet assets and liabilities to be translated to U.S. Dollars at the exchange rate as of quarter end. Stockholders' equity is translated at historical exchange rates and retained earnings are translated at an average exchange rate for the period. Additionally, revenue and expenses are translated at average exchange rates for the periods presented. The resulting cumulative translation adjustment is carried on the balance sheet and is recorded in stockholders' equity for 2017. Since the Company believes that it is more likely than not that no income tax benefit will occur if the foreign equity is sold or liquidated, the cumulative translation adjustment has not been tax adjusted.

Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the three months ended February 28, 2017. Actual results could differ from those estimates.

Reclassification

Certain amounts in the consolidated financial statements of the Company related to the discontinuation of operations at our Vessels segment have been reclassified to conform to classifications used in the current year. The reclassifications had no effect on previously reported results of operations or retained earnings.

6

3)

Discontinued Operations

Effective October 31, 2016, the Company discontinued the operations of its Vessels segment in order to focus its efforts and resources on the business segments that have historically been more successful and that are expected to present greater opportunities for meaningful long-term shareholder returns. Our plan is to dispose of these assets over the next several quarters. At this time, we are working to dispose of the remaining assets, primarily the real estate.

As Vessels was a unique business unit of the Company, its liquidation was a strategic shift. In accordance with Accounting Standard Code Topic 360, the Company has classified Vessels as discontinued operations for all periods presented.

Income from discontinued operations, before income taxes in the accompanying Condensed Consolidated Statements of Operations is comprised of the following:

Three Months Ended

February 28, 2017

February 29, 2016

Revenue from external customers

$ - $ 679,316

Gross Profit

- 74,417

Operating Expense

32 146,160

Income (loss) from operations

(32 ) (71,743 )

Income (loss) before tax

4,877 (75,124 )

The components of discontinued operations in the accompanying Condensed Consolidated Balance Sheets are as follows:

February 28, 2017 November 30, 2016
Accounts Receivable - Net $ 7,500 $ 9,700
Property, plant, and equipment, net 1,716,565 1,745,528
Assets of discontinued operations $ 1,724,065 $ 1,755,228

Accounts payable

$ - $ 1,588

Accrued expenses

33,570 50,061

Notes Payable

683,665 715,945
Liabilities of discontinued operations $ 717,235 $ 767,594

4)

Net Income (Loss) Per Share of Common Stock

Basic net income (loss) per common share has been computed on the basis of the weighted average number of common shares outstanding. Diluted net income (loss) per share has been computed on the basis of the weighted average number of common shares outstanding plus equivalent shares assuming exercise of stock options. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings (loss) per common share .

7

Basic and diluted earnings (loss) per common share have been computed based on the following as of February 28, 2017 and February 29, 2016:

For the three months ended

February 28, 2017

February 29, 2016

Numerator for basic and diluted (loss) earnings per common share:

Net (loss) income from continuing operations

$ (253,642 ) $ 133,549

Net (loss) income from discontinued operations

3,613 (52,587 )

Net (loss) income

$ (250,029 ) $ 80,962

Denominator:

For basic (loss) earnings per share - weighted average common shares outstanding

4,126,012 4,074,338

Effect of dilutive stock options

- -

For diluted (loss) earnings per share - weighted average common shares outstanding

4,126,012 4,074,338

Earnings (Loss) per share - Basic:

Continuing Operations

$ (0.06 ) $ 0.03

Discontinued Operations

$ 0.00 $ (0.01 )

Net Income (Loss) per share

$ (0.06 ) $ 0.02

Earnings (Loss) per share - Diluted:

Continuing Operations

$ (0.06 ) $ 0.03

Discontinued Operations

$ 0.00 $ (0.01 )

Net Income (Loss) per share

$ (0.06 ) $ 0.02

5)

Inventory

Major classes of inventory are:

February 28, 2017

November 30, 2016

Raw materials

$ 8,532,655 $ 8,568,624

Work in process

440,902 509,198

Finished goods

6,898,083 7,054,736
$ 15,871,640 $ 16,132,558

Less: Reserves

(2,638,263 ) (2,603,206 )
$ 13,233,377 $ 13,529,352

8

6)

Accrued Expenses

Major components of accrued expenses are:

February 28, 2017

November 30, 2016

Salaries, wages, and commissions

$ 454,506 $ 542,449

Accrued warranty expense

125,672 134,373

Other

272,229 342,234
$ 852,407 $ 1,019,056

7)

Product Warranty

The Company offers warranties of various lengths to its customers depending on the specific product and terms of the customer purchase agreement. The average length of the warranty period is one year from the date of purchase. The Company's warranties require it to repair or replace defective products during the warranty period at no cost to the customer. The Company records a liability for estimated costs that may be incurred under its warranties. The costs are estimated based on historical experience and any specific warranty issues that have been identified. Although historical warranty costs have been within expectations, there can be no assurance that future warranty costs will not exceed historical amounts. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the balance as necessary. The accrued warranty balance is included in accrued expenses as shown in Note 6. Changes in the Company's product warranty liability for the three months ended February 28, 2017 and February 29, 2016 are as follows:

For the three months ended

February 28, 2017

February 29, 2016

Balance, beginning

$ 134,373 $ 176,531

Settlements / adjustments

(72,949 ) (81,292 )

Warranties issued

64,248 76,702

Balance, ending

$ 125,672 $ 171,941

8)

Loan and Credit Agreements

The Company maintains a revolving line of credit and term loans with U.S. Bank as well as a term loan with The First National Bank of West Union (n/k/a Bank 1 st ). Pursuant to a Second Loan Modification Agreement dated July 12, 2016 and effective July 11, 2016 (the "Loan Modification") entered into among U.S. Bank, as lender, the Company, as borrower, and Art's-Way Scientific, Inc., Art's-Way Vessels, Inc., and Ohio Metal Working Products/Art's-Way, Inc., as guarantors, the agreements governing the U.S. Bank line of credit and certain term loans were amended, and a $200,000 line of credit that the Company had opened to facilitate dealer floorplan financing , but had not drawn on, was terminated along with the related agreements. The description that follows reflects such arrangements as amended by the Loan Modification. Following the close of the first quarter, U.S. Bank, as lender, the Company, as borrower, and Art's-Way Scientific, Inc. and Ohio Metal Working Products/Art's-Way, Inc., as guarantors, entered into a Third Loan Modification Agreement dated March 30, 2017 and effective as of May 1, 2017 with respect to certain modifications to the U.S. Bank UHC Loan (as defined below) and effective as of April 1, 2017 with respect to all other loan modification terms (the "Third Loan Modification") governing the U.S. Bank lines of credit and certain term loans. For more information regarding the Third Loan Modification, see Part II, Item 5 of this Report.